Cargando…

Clinical outcomes and prognostic factors of traumatic basal ganglia hematomas: A 4-year single-center study

BACKGROUND: Traumatic basal ganglia hematomas (TBGH) are rare entities. They are situated in the deep cerebral parenchyma and have also been termed as intermediate coup contusions. Available literature is sparse with regards to the characteristics and prognosis of TBGH. We aim to share our experienc...

Descripción completa

Detalles Bibliográficos
Autores principales: Reddy, Vyjayanth, Pradhan, Aseem, Prasad, G. Lakshmi, Menon, Girish
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Scientific Scholar 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10408632/
https://www.ncbi.nlm.nih.gov/pubmed/37560578
http://dx.doi.org/10.25259/SNI_411_2023
_version_ 1785086205796286464
author Reddy, Vyjayanth
Pradhan, Aseem
Prasad, G. Lakshmi
Menon, Girish
author_facet Reddy, Vyjayanth
Pradhan, Aseem
Prasad, G. Lakshmi
Menon, Girish
author_sort Reddy, Vyjayanth
collection PubMed
description BACKGROUND: Traumatic basal ganglia hematomas (TBGH) are rare entities. They are situated in the deep cerebral parenchyma and have also been termed as intermediate coup contusions. Available literature is sparse with regards to the characteristics and prognosis of TBGH. We aim to share our experience in the management, outcomes, and prognostic factors of TBGH. METHODS: A 4-year retrospective study which included all cases of TBGH, except dot contusions (<2 mL) and those with coagulopathies. Admission variables were correlated with Glasgow Outcome Scale score at discharge and 12 months. RESULTS: Thirty-two patients were analyzed. The mean age was 39.2 years. Two-thirds were due to road traffic accidents. Around 60% were severe head injuries. The mean Glasgow coma scale (GCS) score at presentation was 8.5. Twenty patients had moderate-to-severe hemiparesis. The mean hematoma volume was 18.1 mL. Associated traumatic intracranial lesions were seen in 28 cases. Only 7 patients (22%) underwent surgery. The mean follow-up was 17.4 months (range 14–34 months). The mortality rate was 12.5% (n = 4). Among the survivors, only 39% (n = 11) had good outcomes at discharge which showed modest improvement to 54% (n = 15) at 12 months. CONCLUSION: Our study noted that poor admission GCS scores, poor motor response, presence of significant hemiparesis, and larger hematoma volumes (>20 mL) correlated with poor outcomes at 12 months. The overall outcomes have been mostly unfavorable as observed in majority of studies due to deeper location of these hematomas, high proportion of severe head injuries, and high proportion of residual weakness in survivors.
format Online
Article
Text
id pubmed-10408632
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Scientific Scholar
record_format MEDLINE/PubMed
spelling pubmed-104086322023-08-09 Clinical outcomes and prognostic factors of traumatic basal ganglia hematomas: A 4-year single-center study Reddy, Vyjayanth Pradhan, Aseem Prasad, G. Lakshmi Menon, Girish Surg Neurol Int Original Article BACKGROUND: Traumatic basal ganglia hematomas (TBGH) are rare entities. They are situated in the deep cerebral parenchyma and have also been termed as intermediate coup contusions. Available literature is sparse with regards to the characteristics and prognosis of TBGH. We aim to share our experience in the management, outcomes, and prognostic factors of TBGH. METHODS: A 4-year retrospective study which included all cases of TBGH, except dot contusions (<2 mL) and those with coagulopathies. Admission variables were correlated with Glasgow Outcome Scale score at discharge and 12 months. RESULTS: Thirty-two patients were analyzed. The mean age was 39.2 years. Two-thirds were due to road traffic accidents. Around 60% were severe head injuries. The mean Glasgow coma scale (GCS) score at presentation was 8.5. Twenty patients had moderate-to-severe hemiparesis. The mean hematoma volume was 18.1 mL. Associated traumatic intracranial lesions were seen in 28 cases. Only 7 patients (22%) underwent surgery. The mean follow-up was 17.4 months (range 14–34 months). The mortality rate was 12.5% (n = 4). Among the survivors, only 39% (n = 11) had good outcomes at discharge which showed modest improvement to 54% (n = 15) at 12 months. CONCLUSION: Our study noted that poor admission GCS scores, poor motor response, presence of significant hemiparesis, and larger hematoma volumes (>20 mL) correlated with poor outcomes at 12 months. The overall outcomes have been mostly unfavorable as observed in majority of studies due to deeper location of these hematomas, high proportion of severe head injuries, and high proportion of residual weakness in survivors. Scientific Scholar 2023-07-21 /pmc/articles/PMC10408632/ /pubmed/37560578 http://dx.doi.org/10.25259/SNI_411_2023 Text en Copyright: © 2023 Surgical Neurology International https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-Share Alike 4.0 License, which allows others to remix, transform, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.
spellingShingle Original Article
Reddy, Vyjayanth
Pradhan, Aseem
Prasad, G. Lakshmi
Menon, Girish
Clinical outcomes and prognostic factors of traumatic basal ganglia hematomas: A 4-year single-center study
title Clinical outcomes and prognostic factors of traumatic basal ganglia hematomas: A 4-year single-center study
title_full Clinical outcomes and prognostic factors of traumatic basal ganglia hematomas: A 4-year single-center study
title_fullStr Clinical outcomes and prognostic factors of traumatic basal ganglia hematomas: A 4-year single-center study
title_full_unstemmed Clinical outcomes and prognostic factors of traumatic basal ganglia hematomas: A 4-year single-center study
title_short Clinical outcomes and prognostic factors of traumatic basal ganglia hematomas: A 4-year single-center study
title_sort clinical outcomes and prognostic factors of traumatic basal ganglia hematomas: a 4-year single-center study
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10408632/
https://www.ncbi.nlm.nih.gov/pubmed/37560578
http://dx.doi.org/10.25259/SNI_411_2023
work_keys_str_mv AT reddyvyjayanth clinicaloutcomesandprognosticfactorsoftraumaticbasalgangliahematomasa4yearsinglecenterstudy
AT pradhanaseem clinicaloutcomesandprognosticfactorsoftraumaticbasalgangliahematomasa4yearsinglecenterstudy
AT prasadglakshmi clinicaloutcomesandprognosticfactorsoftraumaticbasalgangliahematomasa4yearsinglecenterstudy
AT menongirish clinicaloutcomesandprognosticfactorsoftraumaticbasalgangliahematomasa4yearsinglecenterstudy